Evaluating the heterogeneity of B cells and TLS in lung cancer patients for improved immunotherapeutics

Watch this presentation by Dr. Tullia C. Bruno, Assistant Professor, University of Pittsburgh, titled: Evaluating the heterogeneity of B cells and TLS in lung cancer patients for improved immunotherapeutics. This talk was presented at the SelectScience^® Virtual Cancer and Immunology Research Summit 2021.